[1]
2025. Impact of Deucravacitinib on Scalp Psoriasis in a Real-world Prospective Cohort Study in the United States. SKIN The Journal of Cutaneous Medicine. 9, 2 (Mar. 2025), s536. DOI:https://doi.org/10.25251/skin.10.supp.536.